Oncology Firm TransCode Therapeutics Looks To Raise US$25 Million In IPO

Oncology company TransCode Therapeutics, Inc. is set to begin publicly trading its equityon the Nasdaq Capital Market today under the symbol “RNAZ.” The company is looking to raise an aggregate sum of US$25.0 million in its initial public offering.

The offering will consist of 6,250,000 common shares priced at US$4.00 per share. The underwriters were also granted a 45-day over-allotment option to purchase an additional 937,500 common shares at the same offering price, bringing the possible proceeds of the offering to US$28.8 million.

In its statement, TransCode refers to itself as an RNA oncology company centered on the belief that cancer can be addressed through RNA therapeutics. Proceeds from the offering will be intended to progress the trial and develop its therapeutic candidate, TTX-MC138, which is focused on treating metastatic cancer.

Cambria Gold Mines — sponsored Sponsored · Cambria Gold Mines

The offering is expected to close on July 13, 2021, subject to customary closing conditions. Fordham Financial division ThinkEquity acts as the sole underwriter for the offering.


Information for this briefing was found via Sedar and TransCode. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

Questcorp Begins 600 Metre Phase 2B Drill Program at La Union

Selkirk Copper Wraps 54,579 Metre Phase 2 Program at Minto, Hits 5.97% Copper Equivalent

Related News

Medical Cannabis Firm Akanda Prices US$16 Million IPO

International medical cannabis firm Akanda Corp. (Nasdaq: AKAN) goes public today on the Nasdaq Capital...

Tuesday, March 15, 2022, 02:26:00 PM

Electric Vehicle Maker Rivian Prices Upsized US$11.9 Billion IPO

Start-up electric vehicle maker Rivian Automotive, Inc. (Nasdaq: RIVN) started trading on the Nasdaq Global...

Wednesday, November 10, 2021, 02:17:00 PM

Tampa Bay Rays Owner-Led SPAC Counter Press Acquisition Prices US$75 Million IPO

Special purpose acquisition company Counter Press Acquisition Corp. (Nasdaq: CPAQU) started trading publicly on the...

Thursday, February 10, 2022, 02:21:00 PM

Geely’s Electric Car Brand Zeekr Reportedly Filed For US IPO

Zeekr, a premium electric car brand owned by China’s Geely, announced Tuesday that it has...

Wednesday, December 14, 2022, 08:30:00 AM

Eye Care Firm Bausch + Lomb Seeks To Raise $630 Million In NYSE, TSX IPOs

Bausch Health Companies (NYSE/TSX: BHC) subsidiary, eye health company Bausch + Lomb Corporation (NYSE/TSX: BLCO)...

Friday, May 6, 2022, 02:24:00 PM